Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.
about
Radiomics: extracting more information from medical images using advanced feature analysisRadiomics: the process and the challengesMagnetic resonance perfusion imaging in neuro-oncology.Classic models for dynamic contrast-enhanced MRI.Advanced magnetic resonance imaging of the physical processes in human glioblastoma.Assessing Treatment Response Through Generalized Pharmacokinetic Modeling of DCE-MRI Data.Can DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors?Cardiovascular magnetic resonance in carotid atherosclerotic disease.MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI.Spatial heterogeneity analysis of brain activation in fMRITargeted therapies in renal cell cancer: recent developments in imagingDynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.Dynamic contrast-enhanced imaging techniques: CT and MRIBiology, genetics and imaging of glial cell tumoursBlood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research.Impact of imaging measurements on response assessment in glioblastoma clinical trialsDecoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerDCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomasBreast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaDCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6.Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesOpportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRINanoagonist-mediated endothelial tight junction opening: A strategy for safely increasing brain drug delivery in mice.Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location.Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters.Effect of a computer-aided diagnosis system on radiologists' performance in grading gliomas with MRI.Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis.Evaluation of Head and Neck Tumors with Functional MR Imaging.Quantitative assessment of tumor responses after radiation therapy in a DLD-1 colon cancer mouse model using serial dynamic contrast-enhanced magnetic resonance imagingTexture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancerPhase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumoursComparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRIBevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI.Diagnostic value of dynamic contrast-enhanced magnetic resonance imaging in rectal cancer and its correlation with tumor differentiation.Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.
P2860
Q23760733-A6B829ED-BB2E-43C2-BE53-2E1FAA9D90A6Q26865378-1898CF50-263F-44A8-A033-72C8C48ACA67Q30479156-B6FAFB96-886F-4324-BE27-FCBD494BDDC3Q30626277-7E5D0AE8-0AC7-4147-BE7C-70A64BB09756Q30847284-0E599D63-56AD-4DB5-9F43-E01421056047Q30990964-2EC0ECB5-46A6-45CC-A17A-AB1AB552384EQ33489265-980A18AA-5848-4148-88BE-4078C4B4896FQ33592226-73AF94B5-5932-472D-A80C-6EB24B70C84CQ33989239-62126D5A-A31E-4FF8-9C0F-40C6A944C918Q34040125-AFE563C1-7B89-48BD-B902-9F2DCC388BA5Q34079267-933F25F5-DECE-48C1-B38D-471B6633B16CQ34088696-44D1FD66-BCA4-405A-B15C-18FA636AF1AEQ34111200-87FCB265-55D4-4387-948E-F098CF98C6E4Q34172445-1620448E-4478-4718-B971-1912EDFEC0B8Q34203923-42D768C4-82B2-43C9-A533-FEB5CDA92365Q34203979-080429F2-8E32-4C9F-A935-BC6831438610Q34251711-2CAF5E39-F303-4413-84FD-380F313FFCCAQ34331328-BF433C5C-8331-41B4-B84B-3C213E3EFAC2Q34535601-9814BCDE-7F0A-43A5-A9A5-8D4215409440Q34538659-F6747F8C-33B1-445C-83F1-3C9937A34AF4Q34582022-E2F4D9B1-01E3-4174-BB9A-C083E2E1627DQ34611146-C084735A-0EDC-447D-B7E3-C3CA58E15494Q34983575-909DA833-C83A-4A09-807F-30ADC1A1DE6EQ35108363-09CDA431-301A-4737-B44A-6F1CE6A781E1Q35223964-F675E517-9FE3-4539-BFD2-0BEBA19D67D8Q35673572-401C2357-B72D-4816-B3B8-F2A2C7565A51Q35786155-98E486DD-3017-4777-889C-7D2473BB5B65Q36061354-E2A32374-3A09-44BB-96B0-30A90B9FDFEBQ36154645-DA755AC1-2A51-4004-A931-A4C7A56DD76EQ36256130-EBED2525-02EE-4E3C-908F-69FD14F55252Q36269782-EE35B7C5-8E10-4DA6-B08D-BA2EE3F0B82FQ36323960-CD774E51-2D47-42E4-8E7F-6F57B7E7318FQ36330208-AC7D4882-AB69-4547-A046-1EAE1190888CQ36347971-B9BA1B14-0864-402D-B7AB-85942E023607Q36515722-895E6A8C-4700-4ABD-A162-D76CAA2F0972Q36557802-B90C6DAA-1D1B-4EE3-9587-3CA9AE00EDE9Q36578820-F73254EA-34C0-4E52-95F1-9C49F40D0E8EQ36640234-E45AABED-81B3-4A99-9E96-483252117458Q36741067-8FEA4583-0554-455A-B868-CD1D97A2D057Q36800482-8B396D75-2C4A-445E-AC5C-5A25E83FA12B
P2860
Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Imaging tumor vascular heterog ...... ed magnetic resonance imaging.
@en
type
label
Imaging tumor vascular heterog ...... ed magnetic resonance imaging.
@en
prefLabel
Imaging tumor vascular heterog ...... ed magnetic resonance imaging.
@en
P50
P1476
Imaging tumor vascular heterog ...... ced magnetic resonance imaging
@en
P2093
James P B O'Connor
P304
P356
10.1158/1078-0432.CCR-07-0238
P407
P577
2007-06-01T00:00:00Z